Olema Pharmaceuticals (OLMA): Price and Financial Metrics

Olema Pharmaceuticals (OLMA): $11.62

0.09 (+0.78%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add OLMA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#303 of 328

in industry

OLMA Price/Volume Stats

Current price $11.62 52-week high $17.79
Prev. close $11.53 52-week low $8.51
Day low $11.51 Volume 295,800
Day high $11.94 Avg. volume 746,778
50-day MA $12.01 Dividend yield N/A
200-day MA $12.14 Market Cap 665.43M

OLMA Stock Price Chart Interactive Chart >


Olema Pharmaceuticals (OLMA) Company Bio


Olema Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of targeted therapies for women's cancers. The company also focuses on OP-1250, a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD) that is being studied in a Phase 1/2 clinical trial for the treatment of metastatic or locally advanced ER-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Olema Pharmaceuticals was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.


OLMA Latest News Stream


Event/Time News Detail
Loading, please wait...

OLMA Latest Social Stream


Loading social stream, please wait...

View Full OLMA Social Stream

OLMA Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!